Patient exposure to PF-ILD in the respiratory digestive and endocrine domains is a suspected disease, clinical performance is complex and often involves multiple systemic burdens. Early identification and standardized diagnosis are essential for improving prognosis. Diagnosis of the disease requires a combination of clinical performance, imaging, laboratory testing and pathological activation.
A platform can assist in matching a team of domestic and foreign authorities to provide accurate diagnosis and treatment programs. Treatment and management of PF-ILD inpatient exposure requires individualized development, typically including multidimensional management of drug therapy, rehabilitation, regular follow-up, etc. In recent years, with the development of treatment-oriented, immune-regulatory therapy and precision medicine, many previously difficult to treat infectious respiratory digestive endocrine disorders have been significantly improved.
Treatment requires close monitoring of therapeutic efficacy and adverse reactions, adapting to timely schemes according to disease changes. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of PF-ILD bird contact. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.